Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, Mexico

During May 2009–April 2010, we analyzed 692 samples of pandemic (H1N1) 2009 virus from patients in Mexico. We detected the H275Y substitution of the neuraminidase gene in a specimen from an infant with pandemic (H1N1) 2009 who was treated with oseltamivir. This virus was susceptible to zanamivir and...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Emerging Infectious Diseases
المؤلفون الرئيسيون:	José Ernesto Ramirez-Gonzalez, Elizabeth Gonzalez-Duran, Patricia Alcantara-Perez, Claudia Wong-Arambula, Hiram Olivera-Diaz, Iliana Cortez-Ortiz, Gisela Barrera-Badillo, Ha T. Nguyen, Larisa Gubareva, Irma Lopez-Martinez, Jose Alberto Díaz-Quiñonez, Miguel Angel Lezana-Fernández, Hugo Lopez Gatell-Ramírez, Jose Angel Cordova Villalobos, Mauricio Hernández-Avila, Celia M. Alpuche-Aranda
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Centers for Disease Control and Prevention 2011-02-01
الموضوعات:	Oseltamivir influenza neuraminidase G1N1 pandemic viruses
الوصول للمادة أونلاين:	https://wwwnc.cdc.gov/eid/article/17/2/10-0897_article

مواد مشابهة

Multicountry Spread of Influenza A(H1N1)pdm09 Viruses with Reduced Oseltamivir Inhibition, May 2023–February 2024
حسب: Mira C. Patel, وآخرون
منشور في: (2024-07-01)

Oseltamivir-resistant influenza in a fatal immunocompromised adult
حسب: Hao-En Jan, وآخرون
منشور في: (2025-08-01)

Reduced Sensitivity of Influenza A (H5N1) to Oseltamivir
حسب: Jennifer L. McKimm-Breschkin, وآخرون
منشور في: (2007-09-01)

OSELTAMIVIR AS ANTIVIRAL THERAPY OF INFLUENZA A(H1N1)pdm09 IN CHILDREN AND ADULTS
حسب: L. V. Osidak, وآخرون
منشور في: (2016-09-01)

Assessment of influenza A (H1N1, H3N2) oseltamivir resistance during 2017-2019 in Iran
حسب: Amytis Gholami, وآخرون
منشور في: (2022-08-01)

Interferon Lambda Delays the Emergence of Influenza Virus Resistance to Oseltamivir
حسب: Chiara Medaglia, وآخرون
منشور في: (2021-06-01)

Discovery of Novel Boron-Containing <em>N</em>-Substituted Oseltamivir Derivatives as Anti-Influenza A Virus Agents for Overcoming N1-H274Y Oseltamivir-Resistant
حسب: Ruifang Jia, وآخرون
منشور في: (2022-09-01)

The Synthetic-Technical Development of Oseltamivir Phosphate Tamiflu™: A Race against Time
حسب: Stefan Abrecht, وآخرون
منشور في: (2007-03-01)

A novel N-heterocycles substituted oseltamivir derivatives as potent inhibitors of influenza virus neuraminidase: discovery, synthesis and biological evaluation
حسب: Jiwei Zhang, وآخرون
منشور في: (2023-12-01)

Detection of H275Y Mutation Conferring Oseltamivir Drug Resistance in Influenza A (H1N1) pdm09 Virus
حسب: Khushbu Trivedi, وآخرون
منشور في: (2021-09-01)

Design, Synthesis, Biological Evaluation and In Silico Studies of Pyrazole-Based NH<sub>2</sub>-Acyl Oseltamivir Analogues as Potent Neuraminidase Inhibitors
حسب: Jiqing Ye, وآخرون
منشور في: (2021-04-01)

Poor responses to oseltamivir treatment in a patient with influenza A (H7N9) virus infection
حسب: Xuhui Liu, وآخرون
منشور في: (2013-01-01)

Structural Investigations and Binding Mechanisms of Oseltamivir Drug Resistance Conferred by the E119V Mutation in Influenza H7N9 Virus
حسب: Samuel C. Ugbaja, وآخرون
منشور في: (2022-07-01)

Clinical and pharmacological approaches to present-day influenza anti-viral therapy
حسب: N. B. Lazareva, وآخرون
منشور في: (2018-04-01)

Oseltamivir-Resistant Influenza A(H1N1)pdm09 Viruses, United States, 2013–14
حسب: Margaret Okomo-Adhiambo, وآخرون
منشور في: (2015-01-01)

Different Inhibitory Potencies of Oseltamivir Carboxylate, Zanamivir, and Several Tannins on Bacterial and Viral Neuraminidases as Assessed in a Cell-Free Fluorescence-Based Enzyme Inhibition Assay
حسب: Stefanie Quosdorf, وآخرون
منشور في: (2017-11-01)

A critical analytical aspect on analytical protocols in the pharmaceutical analysis of H1N1 antiviral agent and its active metabolite
حسب: Suraj R. Chaudhari, وآخرون
منشور في: (2024-08-01)

In Vitro Characterization of Multidrug-Resistant Influenza A(H1N1)pdm09 Viruses Carrying a Dual Neuraminidase Mutation Isolated from Immunocompromised Patients
حسب: Emi Takashita, وآخرون
منشور في: (2020-09-01)

Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States
حسب: Samuel B. Graitcer, وآخرون
منشور في: (2011-02-01)

Oseltamivir-Resistant Pandemic (H1N1) 2009 in Patient with Impaired Immune System
حسب: Grant A. Hill-Cawthorne, وآخرون
منشور في: (2010-07-01)

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil
حسب: Camila Marx, وآخرون
منشور في: (2013-05-01)

Outcomes of Oseltamivir Treatment for H1N1 Infection During Pregnancy: A Retrospective Study
حسب: Nermin Akdemir, وآخرون
منشور في: (2011-04-01)

Oseltamivir-resistant influenza A(H1N1)pdm09 virus in southern Brazil
حسب: Camila Marx, وآخرون
منشور في: (2013-05-01)

Genomic Diversity of Oseltamivir-Resistant Influenza Virus A (H1N1), Luxembourg, 2007–08
حسب: Nancy A. Gerloff, وآخرون
منشور في: (2009-09-01)

Inhibition of Influenza Virus Replication by Oseltamivir Derivatives
حسب: Renee W. Y. Chan, وآخرون
منشور في: (2022-02-01)

Oseltamivir for the treatment of influenza in children and adolescents
حسب: Alfredo Tagarro, وآخرون
منشور في: (2019-05-01)

Manfaat Oseltamivir Terhadap Perbaikan Klinis Kasus Pandemi Influenza Baru A (H1N1) 2009 Anak
حسب: Dewi Murniati, وآخرون
منشور في: (2016-11-01)

Sirolimus combined with oseltamivir and corticosteroid treatment for a puerpera with severe pneumonia caused by 2009 pandemic H1N1: A case report
حسب: Lijun Suo, وآخرون
منشور في: (2021-12-01)

Possible Transmission of Pandemic (HIN1) 2009 Virus with Oseltamivir Resistance
حسب: Michal Mandelboim, وآخرون
منشور في: (2010-05-01)

Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients
حسب: Cameron Wolfe, وآخرون
منشور في: (2010-11-01)

Influenza: state of knowledge, treatment and prevention
حسب: Anna Majewska, وآخرون
منشور في: (2021-07-01)

Influenza in the COVID-19 era: principles of modern pharmacotherapy
حسب: N. B. Lazareva
منشور في: (2021-10-01)

Neuraminidase Inhibitors in Influenza Treatment and Prevention–Is It Time to Call It a Day?
حسب: César Parra-Rojas, وآخرون
منشور في: (2018-08-01)

Combination therapy of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with seasonal influenza
حسب: Parvaiz A Koul, وآخرون
منشور في: (2024-01-01)

Detection of Pandemic (H1N1) 2009 Virus in Patients Treated with Oseltamivir
حسب: David Boutolleau, وآخرون
منشور في: (2010-02-01)

Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution
حسب: Xiaonan Zhang, وآخرون
منشور في: (2014-01-01)

Determination of Oseltamivir Resistance Level by an H275Y Genotyping Assay among Influenza A (H1N1) Viruses in Hamadan Province, Iran
حسب: Shahab Mahmoudvand, وآخرون
منشور في: (2022-08-01)

Effects of dexamethasone coadministered with oseltamivir on the pharmacokinetics of oseltamivir in healthy volunteers
حسب: Jang K, وآخرون
منشور في: (2017-03-01)

Oseltamivir-Resistant Influenza Virus A (H1N1), Europe, 2007–08 Season
حسب: Adam Meijer, وآخرون
منشور في: (2009-04-01)

Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
حسب: Honglin Chen, وآخرون
منشور في: (2009-12-01)